Trials / Unknown
UnknownNCT04732234
Pre-emptive US Guided Superior Hypogastric Plexus Block in Pelvic Cancer Surgeries : a Randomized Double-Blinded Study
Pre-emptive Ultrasound Guided Superior Hypogastric Plexus Block in Pelvic Cancer Surgeries : a Randomized Double-Blinded Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The superior hypogastric plexus (SHP) is a retroperitoneal structure with a predominance of afferent sympathetic nerve fibers. The perception of central pelvic pain is thought mainly to involve transmission through this plexus. Therefore, blocking or of SHP has been used to treat pelvic pain.
Detailed description
Ultrasound guided superior hypogastric plexus block there is 2 equal groups: Group S (SHPB group 18 patients) ultrasound guided SHPB is done after induction of balanced general anesthesia (fentanyl, propofol and rocuronium) using 20 ml Bupivacaine 0.5% before skin incision, Group C (Control group 18 patients) in which same technique will be done but using normal saline 0.9% instead of bupivacaine. Patients of both groups will receive patient controlled analgesia using morphine with continous background infusion of morphine 1.5 mg/h with adding granisterone 2mg/60 ml and ability to give bolus of 0.5 mg morphine on demand. • Dosing and administration; Group S (SHPB group 18 ultrasound guided SHPB ) using 20 ml Bupivacaine 0.5% before skin incision. Group C (Control group 18 patients) in which same technique will be done but using normal saline 0.9%
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Superior Hypogastric Plexus Block | Pre operative ultrasound guided superior hypogastric plexus block in pelvic surgeries using a curvilinear probe below umbalicus with needle in plane technique to reach the plexus in front of L5 vertebra |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-05-01
- Completion
- 2021-05-01
- First posted
- 2021-02-01
- Last updated
- 2021-02-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04732234. Inclusion in this directory is not an endorsement.